Frontal lobe hypometabolism and depression in Alzheimer's disease

Neurology

Volumn 50, Issue 2, 1998, Pages 380-383

  Hirono, N ^a   Mori, E ^a   Ishii, K ^a   Ikejiri, Y ^a   Imamura, T ^a   Shimomura, T ^a   Hashimoto, M ^a   Yamashita, H ^a   Sasaki, M ^a  

^a Hyogo Institute for Aging Brain and Cognitive Disorders   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CINGULATE GYRUS; DEPRESSION; FEMALE; FRONTAL LOBE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0031910490     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.2.380     Document Type: Article

References (28)

1. Cummings JL. The neuroanatomy of depression. J Clin Psychiatry 1993;54(suppl 11):14-20.
2. Mayberg HS. Clinical correlates of PET- and SPECTidentified defects in dementia. J Clin Psychiatry 1994; 55(suppl 11):12-21.
3. Robinson RG, Szetela B. Mood change following left hemispheric brain injury. Ann Neurol 1981;9:447-453.
4. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients: importance of location of lesion. Brain 1984;107:81-93.
5. Cohen RM, Semple WE, Gross M, et al. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 1989; 2:241-254.
6. Baxter LR Jr, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46:243-250.
7. Martinot JL, Hardy P, Feline A, et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 1990;147:1313-1317.
8. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RSJ, Dolan RJ. The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992;22: 607-615.
9. George MS, Ketter TA, Post RM. SPECT and PET imaging in mood disorders. J Clin Psychiatry 1993;54(suppl 11):6-13.
10. Mayberg HS. Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci 1994;6:428-442.
11. Cummings JL, Victoroff JL Noncognitive neuropsychiatrie syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1990;3:140-158.
12. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989;146:577-587.
13. Cummings JL, Ross W, Absher J, Gornbein J, Hadjiaghai L. Depressive symptoms in Alzheimer disease: assessment and determinants. Alzheimer Dis Assoc Disord 1995;9:87-93.
14. Sultzer DL, Mahler ME, Mandelkern MA, et al. The relationship between psychiatrie symptoms and regional cortical metabolism in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1995;7:476-484.
15. Craig AH, Cummings JL, Fairbanks L, et al. Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol 1996;53:1116-1120.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
18. Hughes CP, Berg L, Danziger \VL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
19. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatrie Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
21. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46:130-135.
22. Hirono N, Mori E, Ikejiri Y, et al. Japanese version of the Neuropsychiatrie Inventory: a scoring system for neuropsychiatrie disturbances in dementia patients. Brain Nerve 1997;49: 266-271.
23. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Mori E. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997;38:925-928.
24. lida H, Miura S, Kanno I, et al. Design of evaluation of Headtome IV: a whole body positron emission tomograph. IEEE Trans Nucl Sci 1989;NS-37:1006-1010.
25. Phelps ME, Huang SC, Huffman EJ, Selin C, Sokoloff L, Kühl DE. Tomographie measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388.
26. Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879-887.
27. Rapoport SI. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. Cerebrovasc Brain Metab Rev 1991;3:297-335.
28. Cummings JL, Benson DF: Dementia: a clinical Approach, 2nd ed. Boston: Butterworth-Heinemann, 1992.